問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberBAY59-7939/11630

2006-12-18 - 2010-09-07

Phase III

Terminated13

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 江福田 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 黃啟宏 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 邱恆正 Division of Cardiovascular Diseases
  • 王榮添 Division of Cardiovascular Diseases
  • 周柏青 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung-I Yeh Division of Cardiovascular Diseases

Co-Principal Investigator

  • 蘇正煌 Division of Cardiovascular Diseases
  • 吳懿哲 Division of Cardiovascular Diseases
  • 藍偉仁 Division of Cardiovascular Diseases
  • 郭任遠 Division of Cardiovascular Diseases
  • 洪大川 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 殷偉賢 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 黃文彬 Division of Cardiovascular Diseases
  • 任勗龍 Division of Cardiovascular Diseases
  • 王鑑忠 Division of Cardiovascular Diseases
  • 江孟橙 Division of Cardiovascular Diseases
  • 馮安寧 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator I-Chang Hsieh Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Pei-Ying Pai Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 翁國昌 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 陳清埤 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 丁革新 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 黃崔源 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 鄭成泉 Division of Cardiovascular Diseases
  • 顧博明 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 蔡良敏 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 謝元凱 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 傅懋洋 Division of Cardiovascular Diseases
  • 鄭正一 Division of Cardiovascular Diseases
  • 郭必芳 Division of Cardiovascular Diseases
  • 陳勉成 Division of Cardiovascular Diseases
  • 蔡慧玲 Division of Cardiovascular Diseases
  • 吳炯仁 Division of Cardiovascular Diseases
  • 陳建仁 Division of Cardiovascular Diseases
  • 葉漢根 Division of Cardiovascular Diseases
  • 楊正旭 Division of Cardiovascular Diseases
  • 方志元 Division of Cardiovascular Diseases
  • 洪志凌 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Min-Ji Charng Division of Cardiovascular Diseases

Co-Principal Investigator

  • 李興文 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung-I Yeh Division of Cardiovascular Diseases

Co-Principal Investigator

  • 藍偉仁 Division of Cardiovascular Diseases
  • 洪大川 Division of Cardiovascular Diseases
  • 蘇正煌 Division of Cardiovascular Diseases
  • 吳懿哲 Division of Cardiovascular Diseases
  • 郭任遠 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    159 participants

  • Global

    17232 participants